US2002160476A1PendingUtilityA1
Nucleic acids and proteins from cenarchaeum symbiosum
Est. expirySep 29, 2018(expired)· nominal 20-yr term from priority
C07K 14/195
50
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present application relates to nucleic acids and polypeptides from Cenarchaeum symbiosum. Methods of making the polypeptides and antibodies against the polypeptides are also described.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . An isolated or purified polypeptide comprising a sequence selected from the group consisting of SEQ ID NOS: 6, 10, 14, 26, 28, 30, 32, 34, 38, 42, 46, 58, 60, 62, 64, 66,68, 72, 76, and 80.
2 . An isolated or purified polypeptide comprising at least 10 consecutive amino acids of the polypeptides of claim 1 .
3 . An isolated or purified polypeptide having at least 70% homology to the polypeptide of claim 1 as determined by analysis with FASTA version 3.0t78 with the 25 default parameters.
4 . An isolated or purified polypeptide having at least 99% homology to the polypeptide of claim 1 as determined by analysis with FASTA version 3.0t78 with the default parameters.
5 . An isolated or purified polypeptide having at least 70% homology to the polypeptide of claim 2 as determined by analysis with FASTA version 3.0t78 with the default parameters.
6 . An isolated or purified polypeptide having at least 99% homology to the polypeptide of claim 2 as determined by analysis with FASTA version 3.0t78 with the default parameters.
7 . An isolated or purified polypeptide comprising a sequence selected from the group consisting of SEQ ID NOS: 4, 8, 12, 16, 18, 20, 22, 24, 36, 40, 44, 48, 50, 52, 54, 56,70,74, and 78.
8 . An isolated or purified polypeptide comprising at least 10 consecutive amino acids of the polypeptides of claim 7 .
9 . An isolated or purified polypeptide having at least 70% homology to the polypeptides of claim 7 as determined by analysis with FASTA version 3.0t78 with the default parameters.
10 . An isolated or purified polypeptide having at least 99% homology to the polypeptides of claim 7 as determined by analysis with FASTA version 3.0t78 with the default parameters.
11 . An isolated or purified polypeptide having at least 70% homology to the polypeptides of claim 8 as determined by analysis with FASTA version 3.0t78 with the default parameters.
12 . An isolated or purified polypeptide having at least 99% homology to the polypeptides of claim 8 as determined by analysis with FASTA version 3.0t78 with 20 the default parameters.
13 . A method of making a polypeptide having a sequence selected from the group consisting of SEQ ID NOS: 6, 10, 14, 26, 28, 30, 32, 34, 38, 42, 46, 58, 60, 62, 64, 66, 68, 72, 76, and 80 comprising introducing a nucleic acid encoding said polypeptide, said nucleic acid being operably linked to a promoter, into a host cell.
14 . A method of making a polypeptide comprising at least 10 amino acids of a sequence selected from the group consisting of the sequences of SEQ ID NOS: 6, 10, 14, 26, 28, 30, 32, 34, 38, 42, 46, 58, 60, 62, 64, 66, 68, 72, 76, and 80 comprising introducing a nucleic acid encoding said polypeptide, said nucleic acid being operably linked to a promoter, into a host cell.
15 . A method of making a polypeptide having a sequence selected from the group consisting of SEQ ID NOS: 4, 8, 12, 16, 18, 20, 22, 24, 36, 40, 44, 48, 50, 52, 54, 56, 70, 74, and 78 comprising introducing a nucleic acid encoding said polypeptide, said nucleic acid being operably linked to a promoter, into a host cell.
16 . A method of making a polypeptide comprising at least 10 amino acids of a sequence selected from the group consisting of the sequences of SEQ ID NOS: 4, 8, 12, 16, 18, 20, 22, 24, 36, 40, 44, 48, 50, 52, 54, 56, 70, 74, and 78 comprising introducing a nucleic acid encoding said polypeptide, said nucleic acid being operably linked to a promoter, into a host cell.Join the waitlist — get patent alerts
Track US2002160476A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.